15 days ago
Lisa Vanderpump's nephew, Sam Vanderpump, recently opened up about his ongoing health struggles. The 29-year-old Made in Chelsea star shared that he is still awaiting a liver transplant following his diagnosis of end-stage liver disease.
Sam announced his diagnosis publicly in October 2025. The announcement came months after he suffered severe liver and kidney failure following sepsis in December 2024. In an Instagram post, he shared that he "lives with a genetic liver condition and polycystic kidney disease (PKD)."
While appearing on the October 7 episode of Good Morning Britain, Sam said, "When I was first told that I needed a transplant, they said maybe [in] the next two years I'd have a transplant. I think we're already a year down the line, and luckily my health hasn't deteriorated. But that is the fear."
The reality star, who dyed his hair pink to raise awareness about organ donation, said he has received an overwhelming response from fans. However, he clarified that getting a transplant is not that simple. Sam explained that organ donation follows a "certain procedure" that he cannot arrange himself.
"So if someone were interested in being a live donor for me, they would have to contact the hospital, King's College Hospital, and go through that route themselves," he added. "So, it's kind of like you're caught between a rock and a hard place. You want to get further up the list, but you don't want your health to deteriorate."
#Health #hospital
Sam announced his diagnosis publicly in October 2025. The announcement came months after he suffered severe liver and kidney failure following sepsis in December 2024. In an Instagram post, he shared that he "lives with a genetic liver condition and polycystic kidney disease (PKD)."
While appearing on the October 7 episode of Good Morning Britain, Sam said, "When I was first told that I needed a transplant, they said maybe [in] the next two years I'd have a transplant. I think we're already a year down the line, and luckily my health hasn't deteriorated. But that is the fear."
The reality star, who dyed his hair pink to raise awareness about organ donation, said he has received an overwhelming response from fans. However, he clarified that getting a transplant is not that simple. Sam explained that organ donation follows a "certain procedure" that he cannot arrange himself.
"So if someone were interested in being a live donor for me, they would have to contact the hospital, King's College Hospital, and go through that route themselves," he added. "So, it's kind of like you're caught between a rock and a hard place. You want to get further up the list, but you don't want your health to deteriorate."
#Health #hospital
16 days ago
When a caller mentioned that they are thinking about adding to their position in Simon Property Group, Inc. (NYSE:SPG) during the October 2 episode of Mad Money, Jim Cramer commented:
I think you're absolutely right... I want you to add to the Simon Property Group... What a great man he (David Simon, previous CEO) was, and he built a fabulous company, and you should buy more of it.
A September 8 question about buying Simon Property Group led Cramer to bring another real estate stock into the conversation.
Simon Property Group, Inc. (NYSE:SPG) reported second-quarter real estate funds from operations of $3.29 per diluted share, up 7.9% year-over-year. Domestic property net operating income increased 8.5%. Occupancy at its U.S. malls and premium outlets remained at 96%, while base minimum rent increased 6.3% to $62.42 per square foot. Management raised its full-year real estate funds from operations outlook to $13.20 - $13.30 per share. These figures show rent and property-income growth without requiring an increase in occupancy. Leasing activity also remained substantial. During the earnings call, management reported signing approximately 1,200 leases covering more than 4.8 million square feet, with new-deal volume increasing more than 20%.
Stable occupancy does not mean every tenant is healthy. Simon Property Group, Inc. (NYSE:SPG) absorbed approximately one million square feet of ****** e returned through retailer bankruptcies during the quarter. Management said it successfully re-leased the ****** e, helping maintain occupancy. That shows leasing strength, but also a reminder of the work required to preserve rental income. Additional retailer failures could bring more vacancies and replacement costs, even when demand for the properties remains sound.
#occupancy #NYSE #management #estate
I think you're absolutely right... I want you to add to the Simon Property Group... What a great man he (David Simon, previous CEO) was, and he built a fabulous company, and you should buy more of it.
A September 8 question about buying Simon Property Group led Cramer to bring another real estate stock into the conversation.
Simon Property Group, Inc. (NYSE:SPG) reported second-quarter real estate funds from operations of $3.29 per diluted share, up 7.9% year-over-year. Domestic property net operating income increased 8.5%. Occupancy at its U.S. malls and premium outlets remained at 96%, while base minimum rent increased 6.3% to $62.42 per square foot. Management raised its full-year real estate funds from operations outlook to $13.20 - $13.30 per share. These figures show rent and property-income growth without requiring an increase in occupancy. Leasing activity also remained substantial. During the earnings call, management reported signing approximately 1,200 leases covering more than 4.8 million square feet, with new-deal volume increasing more than 20%.
Stable occupancy does not mean every tenant is healthy. Simon Property Group, Inc. (NYSE:SPG) absorbed approximately one million square feet of ****** e returned through retailer bankruptcies during the quarter. Management said it successfully re-leased the ****** e, helping maintain occupancy. That shows leasing strength, but also a reminder of the work required to preserve rental income. Additional retailer failures could bring more vacancies and replacement costs, even when demand for the properties remains sound.
#occupancy #NYSE #management #estate
16 days ago
Former Fox News anchor Megyn Kelly unleashed a tirade at Olivia Rodrigo on Monday (October 5), telling the pop star to "shut up and stick to singing" after she spoke out about the Cornell 7 case.
"Olivia, in sum, you don't know what the f*** you're talking about. Shut up and stick to singing," Kelly said on her SiriusXM show, per Variety. "I liked you better when you were in front of a microphone singing your weird little depressing songs."
On Sunday (October 4), Rodrigo shared a post on her Instagram Story supporting the Jane Doe at the center of the Cornell 7 lawsuit. "Shame on Cornell and on every institution who protects rapists and abusers over women," the "drivers license" singer wrote. "I stand with Jane Doe. Her bravery reverberates across the country and the crimes against her will not go unpunished."
She added, "What she lived through matters, and so does the failure of those who could have intervened but chose not to. She deserves answers, consequences, and lasting change."
Rodrigo was talking about the lawsuit filed against Cornell University by an unnamed student, who accused seven men of raping and drugging her at a frat house party in October 2024. Her lawsuit claims that the university failed to protect her and instead protected the perpetrators.
#lawsuit #jane
"Olivia, in sum, you don't know what the f*** you're talking about. Shut up and stick to singing," Kelly said on her SiriusXM show, per Variety. "I liked you better when you were in front of a microphone singing your weird little depressing songs."
On Sunday (October 4), Rodrigo shared a post on her Instagram Story supporting the Jane Doe at the center of the Cornell 7 lawsuit. "Shame on Cornell and on every institution who protects rapists and abusers over women," the "drivers license" singer wrote. "I stand with Jane Doe. Her bravery reverberates across the country and the crimes against her will not go unpunished."
She added, "What she lived through matters, and so does the failure of those who could have intervened but chose not to. She deserves answers, consequences, and lasting change."
Rodrigo was talking about the lawsuit filed against Cornell University by an unnamed student, who accused seven men of raping and drugging her at a frat house party in October 2024. Her lawsuit claims that the university failed to protect her and instead protected the perpetrators.
#lawsuit #jane
16 days ago
Few eras have captivated pop culture quite like the 90s, a decade forever marked by its unforgettable girl crushes whose charm, talent, and trailblazing style continue to resonate with fans today. From chart-topping singers to silver screen icons, these women defined a generation and helped pave the way for many who followed. Dive in as we celebrate the dazzling stars whose presence on stage, screen, and red carpets made them the ultimate icons for fans everywhere.
Xavier Collin/Image Press Agency / MEGA
Mariah Carey's soaring vocals and unmistakable style set the tone for '90s pop music domination. Known for her powerhouse ballads and shimmering stage presence, she inspired millions by blending vulnerability with fierce confidence. Whether on the charts or dazzling at glamorous events, Carey remains a symbol of resilience and classic diva allure. She made history as the first artist to land a number one single on the Billboard Hot 100 every year for an entire decade, per Britannica.
KCS Presse / MEGA
Pamela Anderson, a celebrated television star and model, transformed the pop culture landscape with her iconic roles and boundary-pushing style. Her dynamic career and enduring activism prove she's more than a screen siren — she's a force for change and self-empowerment. After joining the cast of Baywatch, the show became the most-watched series with over 1.1 billion viewers weekly, according to IMDb.
#culture #icons
Xavier Collin/Image Press Agency / MEGA
Mariah Carey's soaring vocals and unmistakable style set the tone for '90s pop music domination. Known for her powerhouse ballads and shimmering stage presence, she inspired millions by blending vulnerability with fierce confidence. Whether on the charts or dazzling at glamorous events, Carey remains a symbol of resilience and classic diva allure. She made history as the first artist to land a number one single on the Billboard Hot 100 every year for an entire decade, per Britannica.
KCS Presse / MEGA
Pamela Anderson, a celebrated television star and model, transformed the pop culture landscape with her iconic roles and boundary-pushing style. Her dynamic career and enduring activism prove she's more than a screen siren — she's a force for change and self-empowerment. After joining the cast of Baywatch, the show became the most-watched series with over 1.1 billion viewers weekly, according to IMDb.
#culture #icons
16 days ago
Raven-Symoné has regrets about having breast reduction surgery as a teen.
The "That's So Raven" star, 40, has previously opened up about undergoing the procedure after feeling pressure from adults around her.
"I should have done it after ******* rty," she said in a recent episode of the "Allure Perspectives" podcast. "I mean, they still look good, but it was hastily done."
The "Cheetah Girls" actress said she believes she was "too young." She added that she did not mind having larger ******* , quipping, "Oh girl, I got into anything! I was first in line."
"Push these little babies up, they get you anywhere," she told podcast host Jessica Cruel. "These triple Ds were popping."
#symon #allure #girls #jessica
The "That's So Raven" star, 40, has previously opened up about undergoing the procedure after feeling pressure from adults around her.
"I should have done it after ******* rty," she said in a recent episode of the "Allure Perspectives" podcast. "I mean, they still look good, but it was hastily done."
The "Cheetah Girls" actress said she believes she was "too young." She added that she did not mind having larger ******* , quipping, "Oh girl, I got into anything! I was first in line."
"Push these little babies up, they get you anywhere," she told podcast host Jessica Cruel. "These triple Ds were popping."
#symon #allure #girls #jessica
18 days ago
The shrapnel hit Army Lt. Col. Arturo Lincón's body like shattered glass.
One chunk of metal lodged into the left side of his jaw. Another piece sliced through his salivary gland before bouncing off his jaw and piercing the back of his neck, severing an artery and embedding in a vertebra.
Lincón was among dozens of U.S. soldiers injured in an Iranian drone strike on March 1. The attack on the second day of the U.S. war with Iran killed six troops who were providing logistical support of critical supplies at Port Shuaiba in Kuwait.
Whether the military was properly prepared for treating its wounded has become a sharp point of contention. Soldiers and family members have told The ****** ociated Press of a failure to recognize the seriousness of injuries, a poor plan to get the wounded to hospitals and red tape that has hindered follow-up care. The Pentagon has said that the medical care was appropriate.
Nine U.S. service members who were wounded spoke to the AP on the record — rare for troops still in the Army — about what they describe as a medical system that left them in many ways fighting to get treatment on their own.
#arturo
One chunk of metal lodged into the left side of his jaw. Another piece sliced through his salivary gland before bouncing off his jaw and piercing the back of his neck, severing an artery and embedding in a vertebra.
Lincón was among dozens of U.S. soldiers injured in an Iranian drone strike on March 1. The attack on the second day of the U.S. war with Iran killed six troops who were providing logistical support of critical supplies at Port Shuaiba in Kuwait.
Whether the military was properly prepared for treating its wounded has become a sharp point of contention. Soldiers and family members have told The ****** ociated Press of a failure to recognize the seriousness of injuries, a poor plan to get the wounded to hospitals and red tape that has hindered follow-up care. The Pentagon has said that the medical care was appropriate.
Nine U.S. service members who were wounded spoke to the AP on the record — rare for troops still in the Army — about what they describe as a medical system that left them in many ways fighting to get treatment on their own.
#arturo
18 days ago
All products featured on Allure are independently selected by Allure editors. However, when you buy something through our retail links, Condé Nast may earn an affiliate commission.
You can always rely on Fashion Month to churn out the trends, not just for apparel, but for hair, too. Over the last few weeks, the runway has given us sculptural frizz, combover-esque bangs, creative crimping, and countless other looks that make you wonder whether all of the lead hairstylists have colluded to make your morning routine a little more difficult. But behold: the trend we didn't see coming… back. In the ultimate model-off-duty moment, Gigi Hadid was seen wearing a humble zig-zag headband—the quintessential late-'90s and early-2000s hair accessory.
After walking in Miu Miu's Spring/Summer 2027 show on October 4, Hadid was spotted leaving the venue with her long, blonde hair pushed back by a tortoiseshell scalloped headband. Also known as a shark-tooth or comb headband (depending on who you ask, where they grew up, and how old they are), the style has those unmistakable wavy teeth that grip the hair while keeping the face free of any stray tendrils.
Hadid wore it with an otherwise wonderfully uncomplicated look: a loose, white **** on-down left open over a white bra, jeans cinched with a brown leather belt, and white mesh ballet flats decorated with tiny floral embroidery. She carried a brown Miu Miu bag, making the whole thing feel less like a carefully engineered Paris Fashion Week outfit and more like someone running errands after class in 2002—if that person happened to be a supermodel.
#headband #allure
You can always rely on Fashion Month to churn out the trends, not just for apparel, but for hair, too. Over the last few weeks, the runway has given us sculptural frizz, combover-esque bangs, creative crimping, and countless other looks that make you wonder whether all of the lead hairstylists have colluded to make your morning routine a little more difficult. But behold: the trend we didn't see coming… back. In the ultimate model-off-duty moment, Gigi Hadid was seen wearing a humble zig-zag headband—the quintessential late-'90s and early-2000s hair accessory.
After walking in Miu Miu's Spring/Summer 2027 show on October 4, Hadid was spotted leaving the venue with her long, blonde hair pushed back by a tortoiseshell scalloped headband. Also known as a shark-tooth or comb headband (depending on who you ask, where they grew up, and how old they are), the style has those unmistakable wavy teeth that grip the hair while keeping the face free of any stray tendrils.
Hadid wore it with an otherwise wonderfully uncomplicated look: a loose, white **** on-down left open over a white bra, jeans cinched with a brown leather belt, and white mesh ballet flats decorated with tiny floral embroidery. She carried a brown Miu Miu bag, making the whole thing feel less like a carefully engineered Paris Fashion Week outfit and more like someone running errands after class in 2002—if that person happened to be a supermodel.
#headband #allure
20 days ago
Sabrina Carpenter brought playful charm and vintage romance to Bernadette Antwerp's latest knitwear campaign. The singer posed for the brand's Instagram page wearing a soft green knit mini dress. Choosing a daring, open-back silhouette, she commanded instant attention with her effortless take on countryside style. Her striking floral-knit look highlights the label's signature charm while making a memorable style statement for the brand.
For the shoot, Sabrina Carpenter wore a green Bernadette Antwerp knit minidress as she posed on a wooden porch overlooking a lake. The fitted bodice featured white daisy embroidery across the chest and shoulders, along with a bow at the back of the neckline. The open-back design extended from her shoulders to her waist before wrapping around the hips. The dress finished with a short hemline. The "Espresso" singer completed the outfit with a white crochet headscarf tied loosely around her head. Her blonde hair fell in loose waves beneath the scarf.
Carpenter leaned against the porch railing while glancing back over her shoulder for the camera. For the brand's photoshoot, she stood framed by greenery and a quiet lake view, striking a relaxed, sun-drenched pose. Ultimately, the dress gave Carpenter's outdoor shoot a breezy edge, with no major jewelry or accessories competing with the dress's standout cutout.
Carpenter constantly redefines playful, girl-next-door style with her signature charm. She easily transforms a demure floral knit into a surprisingly daring moment. Clearly, the soft green fabric caught the golden evening light with every pose. She effortlessly combines delicate embroidery with a dramatic cutout and relaxed countryside styling. Undoubtedly, Carpenter delivered one of Bernadette Antwerp's standout campaign looks. She continues to show how to wear vintage-inspired knitwear with effortless allure.
The post Sabrina Carpenter's Bernadette Micro Minidress Has the Biggest Cutout appeared first on theFashionSpot.
#bernadette
For the shoot, Sabrina Carpenter wore a green Bernadette Antwerp knit minidress as she posed on a wooden porch overlooking a lake. The fitted bodice featured white daisy embroidery across the chest and shoulders, along with a bow at the back of the neckline. The open-back design extended from her shoulders to her waist before wrapping around the hips. The dress finished with a short hemline. The "Espresso" singer completed the outfit with a white crochet headscarf tied loosely around her head. Her blonde hair fell in loose waves beneath the scarf.
Carpenter leaned against the porch railing while glancing back over her shoulder for the camera. For the brand's photoshoot, she stood framed by greenery and a quiet lake view, striking a relaxed, sun-drenched pose. Ultimately, the dress gave Carpenter's outdoor shoot a breezy edge, with no major jewelry or accessories competing with the dress's standout cutout.
Carpenter constantly redefines playful, girl-next-door style with her signature charm. She easily transforms a demure floral knit into a surprisingly daring moment. Clearly, the soft green fabric caught the golden evening light with every pose. She effortlessly combines delicate embroidery with a dramatic cutout and relaxed countryside styling. Undoubtedly, Carpenter delivered one of Bernadette Antwerp's standout campaign looks. She continues to show how to wear vintage-inspired knitwear with effortless allure.
The post Sabrina Carpenter's Bernadette Micro Minidress Has the Biggest Cutout appeared first on theFashionSpot.
#bernadette
22 days ago
SENSUAL ALLURE: Roberto Cavalli is all about hedonism in its new campaign staged in Los Angeles.
The brand selected "The Shards" star Hayes Warner, who was lensed by Indiana Piorek in a villa that overlooks the city.
More from WWD
Colman Domingo Fronts Away's Campaign for Series 3 and Signature Bag Collections
Cardi B Slides Into Wildlife-inspired Pumps to Sit Front-row at Roberto Cavalli's Spring 2027 Milan Show
#roberto #shards #warner
The brand selected "The Shards" star Hayes Warner, who was lensed by Indiana Piorek in a villa that overlooks the city.
More from WWD
Colman Domingo Fronts Away's Campaign for Series 3 and Signature Bag Collections
Cardi B Slides Into Wildlife-inspired Pumps to Sit Front-row at Roberto Cavalli's Spring 2027 Milan Show
#roberto #shards #warner
23 days ago
NASHVILLE, Tenn. (AP) — The Tennessee governor ordered an outside investigation and halted executions late Wednesday, hours after an inmate survived a lethal injection attempt.
Tennessee officials were unable to put Christa Gail Pike to death for a 1995 murder after administering two doses of a lethal drug. A death penalty expert said it was an unprecedented failure.
Gov. Bill Lee said in a statement that he has ordered "a comprehensive, third-party review to determine exactly what occurred" and that scheduled executions will not be carried out this year.
"Carrying out a lawfully imposed sentence is among the State's most serious responsibilities, and the people of Tennessee expect it to be done in a manner that is not only legal and constitutional, but is effective," he said.
Tennessee only has one other execution scheduled this year.
#tennessee #death #year
Tennessee officials were unable to put Christa Gail Pike to death for a 1995 murder after administering two doses of a lethal drug. A death penalty expert said it was an unprecedented failure.
Gov. Bill Lee said in a statement that he has ordered "a comprehensive, third-party review to determine exactly what occurred" and that scheduled executions will not be carried out this year.
"Carrying out a lawfully imposed sentence is among the State's most serious responsibilities, and the people of Tennessee expect it to be done in a manner that is not only legal and constitutional, but is effective," he said.
Tennessee only has one other execution scheduled this year.
#tennessee #death #year
1 month ago
The CLARITY Act failed to pass votes in the Senate earlier this week, a piece of legislature that would set out guardrails and ground rules for crypto **** ets in the U.S. With the failure of passage, the Securities and Exchange Commission took matters into its own hands, passing a conditional exemption Thursday for tokenized stocks. This Innovation Exemption allows for a limited type of tokenized securities to trade on specific Tokenized Securities Venues (TSVs), giving them a 5-year runway to prove their trading chops.
Tokenization is one of the latest trends in the investing world, whereby an **** et is represented digitally on a blockchain. It's seen as the next frontier in finance, with digital trading opening up greater access both for a broader investor base as well as the potential to trade 24/7, while also offering the potential for increased efficiency. However, some argue that tokenized **** ets come with added, unique risks and that by moving investments to the blockchain you introduce greater exposure to bad actors in an as-yet unregulated **** e in the U.S. That is, until now.
The SEC exemption allows for a specific type of tokenized stocks to be traded, specifically ones that retain the investor rights of the stock they are tied to (voting and dividends for example). Only tokenized U.S. National Market System (NMS) stocks qualify that trade through U.S. venues who have established standards for who can trade, limit trading volumes to a certain percentage of the stock, and make public their trading activities as well as any affiliates on the TSV. In addition, venues must halt trading when the primary exchange halts, and leverage is not permitted. Any company that does not want tokenized shares has 30 days to object and prevent their shares from being created.
It's important to note that currently there are two main types of tokenized securities, those that are directly linked to the **** et they represent digitally and those that provide synthetic exposure. Of the two, only the direct exposure tokenized stocks qualify that meet all of the exemption's restrictions.
"The Commission is not cementing today's technology as the standard for tomorrow. Instead, it is allowing the market to evolve, monitoring its development, and using that insight to inform a nimbler and future-ready regulatory framework," SEC Chair Paul Atkins said in a statement.
#exposure #commission
Tokenization is one of the latest trends in the investing world, whereby an **** et is represented digitally on a blockchain. It's seen as the next frontier in finance, with digital trading opening up greater access both for a broader investor base as well as the potential to trade 24/7, while also offering the potential for increased efficiency. However, some argue that tokenized **** ets come with added, unique risks and that by moving investments to the blockchain you introduce greater exposure to bad actors in an as-yet unregulated **** e in the U.S. That is, until now.
The SEC exemption allows for a specific type of tokenized stocks to be traded, specifically ones that retain the investor rights of the stock they are tied to (voting and dividends for example). Only tokenized U.S. National Market System (NMS) stocks qualify that trade through U.S. venues who have established standards for who can trade, limit trading volumes to a certain percentage of the stock, and make public their trading activities as well as any affiliates on the TSV. In addition, venues must halt trading when the primary exchange halts, and leverage is not permitted. Any company that does not want tokenized shares has 30 days to object and prevent their shares from being created.
It's important to note that currently there are two main types of tokenized securities, those that are directly linked to the **** et they represent digitally and those that provide synthetic exposure. Of the two, only the direct exposure tokenized stocks qualify that meet all of the exemption's restrictions.
"The Commission is not cementing today's technology as the standard for tomorrow. Instead, it is allowing the market to evolve, monitoring its development, and using that insight to inform a nimbler and future-ready regulatory framework," SEC Chair Paul Atkins said in a statement.
#exposure #commission
1 month ago
(Bloomberg) -- The first junk-bond offering for a data center tied to Meta Platforms Inc. attracted demand more than four times the deal's size, with juicy yields helping to lure investors.
Most Read from Bloomberg
Saudis Give European Oil Buyers No Supplies for Next Month
Zuckerberg Has an AI Empire to Build. Meet the Adviser Who Handles the Details
Fed Raises Rates to Curb Inflation, Drawing Rebuke From Trump
#bloomberg #meta #month
Most Read from Bloomberg
Saudis Give European Oil Buyers No Supplies for Next Month
Zuckerberg Has an AI Empire to Build. Meet the Adviser Who Handles the Details
Fed Raises Rates to Curb Inflation, Drawing Rebuke From Trump
#bloomberg #meta #month
1 month ago
On September 8, 2026, CNBC reported that Novartis AG (NYSE:NVS) shares fell about 10% after the company said its experimental drug del-desiran failed to meet its primary goal in a late-stage trial for myotonic dystrophy type 1.
It marked the company's third clinical setback in a week following the earlier failure of cardiovascular drug pelacarsen and a separate pause of eight trials of cell therapy rap-cel after three patient deaths. The decline erased roughly 24 billion Swiss francs, or about $29.6 billion, in market value and put Novartis on pace for one of its worst trading days in company history.
Remibrutinib provides a major remaining pipeline catalyst since Novartis AG (NYSE:NVS) reported successful late-stage results for remibrutinib in multiple sclerosis. It gives investors a credible growth driver after the failures of pelacarsen and del-desiran. The business expects more remibrutinib data later this year, making the drug an important test of whether its remaining pipeline can help long-term growth.
Novartis still expects 5% to 6% annual sales growth through 2030. Management reaffirmed its full-year financial guidance and maintained its target for 5% to 6% compound annual sales growth from 2025 through 2030. That guidance shows the company still expects its overall portfolio and remaining pipeline ******* ets to offset pressure from aging drugs.
The company retains a diversified commercial portfolio. The del-desiran failure removes a potentially important future revenue contributor, but Novartis still makes substantial revenue from its existing medicines. It also retains other pipeline ******* ets. That diversification gives the firm financial capacity to absorb individual clinical failures while it rebuilds investor confidence in its growth pipeline.
#company #remibrutinib
It marked the company's third clinical setback in a week following the earlier failure of cardiovascular drug pelacarsen and a separate pause of eight trials of cell therapy rap-cel after three patient deaths. The decline erased roughly 24 billion Swiss francs, or about $29.6 billion, in market value and put Novartis on pace for one of its worst trading days in company history.
Remibrutinib provides a major remaining pipeline catalyst since Novartis AG (NYSE:NVS) reported successful late-stage results for remibrutinib in multiple sclerosis. It gives investors a credible growth driver after the failures of pelacarsen and del-desiran. The business expects more remibrutinib data later this year, making the drug an important test of whether its remaining pipeline can help long-term growth.
Novartis still expects 5% to 6% annual sales growth through 2030. Management reaffirmed its full-year financial guidance and maintained its target for 5% to 6% compound annual sales growth from 2025 through 2030. That guidance shows the company still expects its overall portfolio and remaining pipeline ******* ets to offset pressure from aging drugs.
The company retains a diversified commercial portfolio. The del-desiran failure removes a potentially important future revenue contributor, but Novartis still makes substantial revenue from its existing medicines. It also retains other pipeline ******* ets. That diversification gives the firm financial capacity to absorb individual clinical failures while it rebuilds investor confidence in its growth pipeline.
#company #remibrutinib
1 month ago
The CLARITY Act's 49-50 Senate failure sent XRP down 8% and invalidated every major **** yst price target built on the bill passing.
ChatGPT's 90-day forecast puts XRP's central estimate at $1.20, down from $1.30, and identifies the $1.20 to $1.23 range as the key near-term battleground.
Weekly XRP ETF inflows fell from $110 million to $19 million, while a second Fed rate hike in October threatens further downside pressure.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
XRP (CRYPTO:XRP) holders spent this year anticipating the Digital **** et Market Clarity Act, a bill intended to write XRP's commodity status into federal law rather than leaving it subject to regulatory changes. The bill reached the Senate floor with 126 Democratic amendments included but failed on a procedural vote on September 15, 2026, with cloture ending 49 to 50.
#clarity #october #Crypto
ChatGPT's 90-day forecast puts XRP's central estimate at $1.20, down from $1.30, and identifies the $1.20 to $1.23 range as the key near-term battleground.
Weekly XRP ETF inflows fell from $110 million to $19 million, while a second Fed rate hike in October threatens further downside pressure.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
XRP (CRYPTO:XRP) holders spent this year anticipating the Digital **** et Market Clarity Act, a bill intended to write XRP's commodity status into federal law rather than leaving it subject to regulatory changes. The bill reached the Senate floor with 126 Democratic amendments included but failed on a procedural vote on September 15, 2026, with cloture ending 49 to 50.
#clarity #october #Crypto
1 month ago
On September 8, 2026, CNBC reported that Novartis' failed pelacarsen trial has raised the stakes for rival experimental cholesterol drugs from Amgen Inc. (NASDAQ:AMGN) and Eli Lilly and Company (NYSE:LLY), both of which are racing to prove that lowering lipoprotein(a), or Lp(a). It can meaningfully reduce heart attacks and strokes.
Analysts said Amgen's olpasiran faces the clearest negative read-through given its similar trial design. Lilly's lepodisiran is being tested in a broader patient population that could limit how directly Novartis' failure applies. It is also described as less material to Lilly's overall valuation than pelacarsen was for Novartis.
Copyright: stocking / 123RF Stock Photo
Amgen Inc. (NASDAQ:AMGN) and Eli Lilly and Company (NYSE:LLY) could still succeed where Novartis failed. Pelacarsen's failure does not establish that lowering Lp(a) cannot reduce cardiovascular events. **** ysts noted that Novartis' trial faced a high statistical hurdle and that Amgen's olpasiran and Lilly's lepodisiran have produced stronger Lp(a) reductions in earlier studies. Both companies also continue testing their drugs in specific patient populations with high Lp(a). It leaves room for their trials to produce different outcomes from Novartis' study.
Lilly's lepodisiran faces a less direct read-through than Amgen's olpasiran. **** ysts view Amgen's olpasiran as the closest comparison to pelacarsen because the programs use similar trial designs. Lilly's lepodisiran is being tested in an overall patient population. It could make Novartis' failure less directly applicable. **** ysts also view lepodisiran as less material to Lilly's overall valuation than pelacarsen was to Novartis. It reduces the potential financial impact of an unsuccessful outcome.
#lepodisiran #less
Analysts said Amgen's olpasiran faces the clearest negative read-through given its similar trial design. Lilly's lepodisiran is being tested in a broader patient population that could limit how directly Novartis' failure applies. It is also described as less material to Lilly's overall valuation than pelacarsen was for Novartis.
Copyright: stocking / 123RF Stock Photo
Amgen Inc. (NASDAQ:AMGN) and Eli Lilly and Company (NYSE:LLY) could still succeed where Novartis failed. Pelacarsen's failure does not establish that lowering Lp(a) cannot reduce cardiovascular events. **** ysts noted that Novartis' trial faced a high statistical hurdle and that Amgen's olpasiran and Lilly's lepodisiran have produced stronger Lp(a) reductions in earlier studies. Both companies also continue testing their drugs in specific patient populations with high Lp(a). It leaves room for their trials to produce different outcomes from Novartis' study.
Lilly's lepodisiran faces a less direct read-through than Amgen's olpasiran. **** ysts view Amgen's olpasiran as the closest comparison to pelacarsen because the programs use similar trial designs. Lilly's lepodisiran is being tested in an overall patient population. It could make Novartis' failure less directly applicable. **** ysts also view lepodisiran as less material to Lilly's overall valuation than pelacarsen was to Novartis. It reduces the potential financial impact of an unsuccessful outcome.
#lepodisiran #less
1 month ago
On September 9, 2026, Reuters reported that Meta Platforms, Inc. (NASDAQ:META) rolled out Muse, a long-touted AI agent that can autonomously send emails, sell a car, and book travel on a person's behalf, despite internal concerns among Meta's own employees that the technology mismanages access to sensitive personal data. The agent is modeled on the open-source system OpenClaw and available initially only in the U.S. through a dedicated app or WhatsApp. It is designed to access apps across email, calendar, payments, health, shopping, and smart-home categories as the centerpiece of CEO Mark Zuckerberg's "personal superintelligence" strategy.
Muse could give Meta Platforms, Inc. (NASDAQ:META) a new revenue stream beyond advertising by turning its massive user base into paying AI customers. The company launched Muse with a free tier and $20 and $100 monthly subscription options for heavier users. The agent can handle tasks such as sending emails, selling items, and booking travel. It gives Meta a direct way to monetize AI capabilities and diversify its revenue base.
The new AI agent could help Meta generate returns from its enormous AI infrastructure investment. Meta expects AI infrastructure spending to exceed $130 billion this year, increasing the importance of monetizing its AI capabilities. Meta can distribute Muse through WhatsApp and eventually connect it with smart glasses. It gives the company multiple ways to expand usage and build a broader consumer AI ecosystem.
Meta has strengthened Muse's safeguards before launching the product. It could support wider use. Meta delayed the launch from April to improve security and added an autonomous safety agent that monitors Muse's actions. Users can also control which apps Muse can access, while Meta plans an encrypted version. It gives the company a path to address security concerns as it expands the product.
Muse's security failures could damage consumer trust in a product that needs access to sensitive information. Internal testing uncovered an incident in which Muse exposed private iCloud photos. Employees also reported other security concerns. Such failures could discourage users from connecting email, payment, health, and other personal accounts, limiting subscription adoption and Meta Platforms, Inc. (NASDAQ:META)'s potential revenue from Muse.
#muse
Muse could give Meta Platforms, Inc. (NASDAQ:META) a new revenue stream beyond advertising by turning its massive user base into paying AI customers. The company launched Muse with a free tier and $20 and $100 monthly subscription options for heavier users. The agent can handle tasks such as sending emails, selling items, and booking travel. It gives Meta a direct way to monetize AI capabilities and diversify its revenue base.
The new AI agent could help Meta generate returns from its enormous AI infrastructure investment. Meta expects AI infrastructure spending to exceed $130 billion this year, increasing the importance of monetizing its AI capabilities. Meta can distribute Muse through WhatsApp and eventually connect it with smart glasses. It gives the company multiple ways to expand usage and build a broader consumer AI ecosystem.
Meta has strengthened Muse's safeguards before launching the product. It could support wider use. Meta delayed the launch from April to improve security and added an autonomous safety agent that monitors Muse's actions. Users can also control which apps Muse can access, while Meta plans an encrypted version. It gives the company a path to address security concerns as it expands the product.
Muse's security failures could damage consumer trust in a product that needs access to sensitive information. Internal testing uncovered an incident in which Muse exposed private iCloud photos. Employees also reported other security concerns. Such failures could discourage users from connecting email, payment, health, and other personal accounts, limiting subscription adoption and Meta Platforms, Inc. (NASDAQ:META)'s potential revenue from Muse.
#muse
1 month ago
On September 7, 2026, Reuters reported that Novo Nordisk A/S (NYSE:NVO) halted two additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker's efforts to diversify beyond its blockbuster obesity and diabetes franchise.
The move follows a July disclosure that ziltivekimab failed to reduce major adverse cardiovascular events in a late-stage trial. An independent data monitoring committee found a "low likelihood" that the two additional heart-failure studies would produce a different result from that earlier failure, prompting Novo to end them ahead of schedule.
Novo Nordisk A/S (NYSE:NVO) still has one opportunity to create value from its cardiovascular program. The company will continue testing ziltivekimab in patients recovering from a heart attack, with results expected in the first half of 2027. A successful outcome could give Novo another growth opportunity outside its obesity and diabetes franchise.
Novo's core obesity and diabetes business remains the much larger driver of its financial performance. The oral Wegovy pill has already generated more than 2 million prescriptions shortly after its January 2026 launch. It gives Novo an important growth opportunity as the company competes with Eli Lilly in the oral GLP-1 market.
The company can also preserve capital by ending trials that show limited prospects for success. An independent data monitoring committee found a low likelihood that the two heart-failure studies would produce different results from the earlier failed trial. Novo can redirect the resources it would have spent on those studies toward higher-potential programs.
#obesity #diabetes
The move follows a July disclosure that ziltivekimab failed to reduce major adverse cardiovascular events in a late-stage trial. An independent data monitoring committee found a "low likelihood" that the two additional heart-failure studies would produce a different result from that earlier failure, prompting Novo to end them ahead of schedule.
Novo Nordisk A/S (NYSE:NVO) still has one opportunity to create value from its cardiovascular program. The company will continue testing ziltivekimab in patients recovering from a heart attack, with results expected in the first half of 2027. A successful outcome could give Novo another growth opportunity outside its obesity and diabetes franchise.
Novo's core obesity and diabetes business remains the much larger driver of its financial performance. The oral Wegovy pill has already generated more than 2 million prescriptions shortly after its January 2026 launch. It gives Novo an important growth opportunity as the company competes with Eli Lilly in the oral GLP-1 market.
The company can also preserve capital by ending trials that show limited prospects for success. An independent data monitoring committee found a low likelihood that the two heart-failure studies would produce different results from the earlier failed trial. Novo can redirect the resources it would have spent on those studies toward higher-potential programs.
#obesity #diabetes
1 month ago
XRP ranks last for Q4 after the CLARITY Act's Senate failure removed every legislative catalyst and invalidated year-end targets built around the bill.
Ethereum leads the Q4 outlook as the only coin carrying a dated technical upgrade still on the calendar, edging out Bitcoin and crushing XRP.
Bitcoin reclaiming $80,000 before the November midterms is the single falsifiable trigger that tightens the base scenario for all three coins.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
The U.S. Senate voted 49-50 against advancing the CLARITY Act on September 15, falling eleven votes short of the 60 needed to end debate. The defeat leaves crypto's market-structure rules in the hands of the SEC and CFTC rather than Congress, at least for the remainder of 2026.
#senate #learn #september
Ethereum leads the Q4 outlook as the only coin carrying a dated technical upgrade still on the calendar, edging out Bitcoin and crushing XRP.
Bitcoin reclaiming $80,000 before the November midterms is the single falsifiable trigger that tightens the base scenario for all three coins.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
The U.S. Senate voted 49-50 against advancing the CLARITY Act on September 15, falling eleven votes short of the 60 needed to end debate. The defeat leaves crypto's market-structure rules in the hands of the SEC and CFTC rather than Congress, at least for the remainder of 2026.
#senate #learn #september
1 month ago
The Commodity and Futures Trading Commission on Thursday paved the way to expand prediction markets and cryptocurrency trading on certain online platforms. DraftKings led a retreat for sports betting stocks Thursday.
The CFTC's Market Participation division issued a no-action letter, saying it will not take enforcement action against providers of what the agency called "passive software."
These passive software providers include companies and developers that offer prediction market, derivatives or crypto trading services, but do not take custody of user ***** ets.
"Subject to certain specified conditions, MPD will not recommend the Commission take enforcement action against any such provider or their relevant personnel for failure to register as an introducing broker or an ***** ociated person of an introducing broker," the regulator said in its announcement. However, this only applies to the "provision and marketing of software to facilitate trading" between users and registered futures commission merchants, introducing brokers, and designated contract merchants.
The decision follows a similar no-action letter from the CFTC in March, which responded to a request from self-custody crypto wallet provider Phantom Technologies, Bloomberg reported. Phantom Technologies partnered with Kalshi to offer predictions market trading to its more than 20 million crypto wallet holders.
#action
The CFTC's Market Participation division issued a no-action letter, saying it will not take enforcement action against providers of what the agency called "passive software."
These passive software providers include companies and developers that offer prediction market, derivatives or crypto trading services, but do not take custody of user ***** ets.
"Subject to certain specified conditions, MPD will not recommend the Commission take enforcement action against any such provider or their relevant personnel for failure to register as an introducing broker or an ***** ociated person of an introducing broker," the regulator said in its announcement. However, this only applies to the "provision and marketing of software to facilitate trading" between users and registered futures commission merchants, introducing brokers, and designated contract merchants.
The decision follows a similar no-action letter from the CFTC in March, which responded to a request from self-custody crypto wallet provider Phantom Technologies, Bloomberg reported. Phantom Technologies partnered with Kalshi to offer predictions market trading to its more than 20 million crypto wallet holders.
#action
1 month ago
Evommune, Inc. (NYSE:EVMN) announced on September 8 that EVO756 missed its primary endpoint in a randomized, double-blind, placebo-controlled Phase 2b trial involving 121 adults with moderate-to-severe atopic dermatitis. The primary measure was the percentage change from baseline in Eczema Area and Severity Index, or EASI, at week 12. No tested dose met the primary or secondary endpoints, and development in that indication will stop.
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p
1 month ago
Freight fraud risks and carrier vetting are the focus as Highway Chief Commercial Officer Michael Caney joins FreightWaves Today. He breaks down what brokers, carriers and shippers need to watch right now when onboarding and monitoring capacity.If you work fraud prevention, carrier compliance or network procurement, this conversation gets straight to the operational takeaway without the fluff.#FreightFraud #CarrierVetting #SupplyChain
Carrier-vetting platform Highway is putting its balance sheet behind its fraud-detection product: if a broker moves freight using Highway's guarantee standard and loses a load, Highway writes a check for $100,000. The company's chief commercial officer said the program covers the vast majority of carrier capacity in North America — and has paid out only once across roughly one million loads.
Of the approximately 175,000 carriers that move freight for freight brokers, Highway says more than 82% qualify for the guarantee tier. "What I would tell you is the industry keeps trying to solve for the bottom 18% of the market," the CCO said. "And what we're saying is if you will just move your freight to this cohort of carriers, which is the majority of capacity in North America, not only will you be fine, but Highway will stand behind it with a performance guarantee."
"The average cargo theft is not the $100,000, it's $250,000. This idea that a motor carrier can just show up and say, hey man, I'm gonna need this cargo, it's $250 grand, I'm good for it, is bananas."
The single payout to date stemmed from an identity-design flaw tied to California's non-domiciled limited-term licensing rules. A fraudulent carrier obtained a new license through California's process, resubmitted in Highway's system, and the alert dropped off before the bug was caught and fixed — costing Highway $100,000. The CCO described theft events as a "Swiss cheese" of compounding decisions rather than a single failure point, and said Highway continuously monitors for ownership changes, inbox compromises, and cyber anomalies within the guarantee framework.
#carriers #capacity #America
Carrier-vetting platform Highway is putting its balance sheet behind its fraud-detection product: if a broker moves freight using Highway's guarantee standard and loses a load, Highway writes a check for $100,000. The company's chief commercial officer said the program covers the vast majority of carrier capacity in North America — and has paid out only once across roughly one million loads.
Of the approximately 175,000 carriers that move freight for freight brokers, Highway says more than 82% qualify for the guarantee tier. "What I would tell you is the industry keeps trying to solve for the bottom 18% of the market," the CCO said. "And what we're saying is if you will just move your freight to this cohort of carriers, which is the majority of capacity in North America, not only will you be fine, but Highway will stand behind it with a performance guarantee."
"The average cargo theft is not the $100,000, it's $250,000. This idea that a motor carrier can just show up and say, hey man, I'm gonna need this cargo, it's $250 grand, I'm good for it, is bananas."
The single payout to date stemmed from an identity-design flaw tied to California's non-domiciled limited-term licensing rules. A fraudulent carrier obtained a new license through California's process, resubmitted in Highway's system, and the alert dropped off before the bug was caught and fixed — costing Highway $100,000. The CCO described theft events as a "Swiss cheese" of compounding decisions rather than a single failure point, and said Highway continuously monitors for ownership changes, inbox compromises, and cyber anomalies within the guarantee framework.
#carriers #capacity #America
1 month ago
Crypto volatility is likely to remain elevated as investors weigh the Federal Reserve's monetary policy decision and the CLARITY Act's failure to advance in a key Senate procedural vote, according to Simon-Peter Massabni, head of business development at XS.com.
Bitcoin (CRYPTO: $BTC) fell more than 2.5% to around $75,600 on Tuesday, while Ethereum (CRYPTO: $ETH), Solana (CRYPTO: $SOL), Cardano (CRYPTO: $ADA) and Dogecoin (CRYPTO: $DOGE) also traded lower.
The Senate's failure to advance the CLARITY Act was a major source of market uncertainty. Senators voted 49-50 on Tuesday, falling well short of the 60 votes required to move the legislation forward. The bill aims to establish a federal framework for digital ****** ets and clarify the regulatory roles of the Securities and Exchange Commission and Commodity Futures Trading Commission.
More From Cryptoprowl:
MEXC Launches Earn Plus With Limited-Time Event Offering Up to 800% APR Booster
#commission #failure #advance #senate
Bitcoin (CRYPTO: $BTC) fell more than 2.5% to around $75,600 on Tuesday, while Ethereum (CRYPTO: $ETH), Solana (CRYPTO: $SOL), Cardano (CRYPTO: $ADA) and Dogecoin (CRYPTO: $DOGE) also traded lower.
The Senate's failure to advance the CLARITY Act was a major source of market uncertainty. Senators voted 49-50 on Tuesday, falling well short of the 60 votes required to move the legislation forward. The bill aims to establish a federal framework for digital ****** ets and clarify the regulatory roles of the Securities and Exchange Commission and Commodity Futures Trading Commission.
More From Cryptoprowl:
MEXC Launches Earn Plus With Limited-Time Event Offering Up to 800% APR Booster
#commission #failure #advance #senate
1 month ago
Ethereum's native token, Ether (ETH), is showing signs of underperformance against Bitcoin (BTC), with a bearish double-top setup emerging just as the US Senate's failure to advance the CLARITY Act adds fresh uncertainty to the crypto market.
Ether was trading near 0.03167 BTC on Sept. 16, after failing to sustain its latest advance against Bitcoin.
The ETH/BTC daily chart shows two comparable peaks near 0.03344 BTC, one formed in August and another in September. Together, they resemble a potential double top, a bearish reversal structure that typically develops when buyers repeatedly fail to push price through the same resistance area.
Its neckline sits around 0.03078 BTC, meaning ETH/BTC would need a decisive daily close below that level to validate the breakdown.
If that happens, subtracting the pattern's maximum height from the neckline produces a downside target near 0.0283 BTC. That would represent a decline of roughly 10% from current levels, signaling further Ethereum underperformance relative to Bitcoin.
#Bitcoin #underperformance #daily #neckline
Ether was trading near 0.03167 BTC on Sept. 16, after failing to sustain its latest advance against Bitcoin.
The ETH/BTC daily chart shows two comparable peaks near 0.03344 BTC, one formed in August and another in September. Together, they resemble a potential double top, a bearish reversal structure that typically develops when buyers repeatedly fail to push price through the same resistance area.
Its neckline sits around 0.03078 BTC, meaning ETH/BTC would need a decisive daily close below that level to validate the breakdown.
If that happens, subtracting the pattern's maximum height from the neckline produces a downside target near 0.0283 BTC. That would represent a decline of roughly 10% from current levels, signaling further Ethereum underperformance relative to Bitcoin.
#Bitcoin #underperformance #daily #neckline
1 month ago
Senate Republicans aren’t happy with the lack of progress in the Iran war and what they say is the administration’s failure to identify clear objectives to end the conflict.
The war continues to be a major drag on GOP candidates as the failure to reopen the Strait of Hormuz and new threats facing oil exports from Iranian-backed Houthi militias have sent the prices to nearly $106 a barrel, while raising the national gas price average to $4.37 a gallon.
But Republicans are particularly concerned about the war’s impact on the price of diesel, which has soared to a national average of $6.31 and hit several Senate battleground states — including Alaska, Nebraska, Iowa and Maine — especially hard.
Some Republicans are now floating the idea of embargoing diesel exports produced in the United States to lower prices.
Republican Sen. Lisa Murkowski (Alaska) expressed frustration over “the lack of just transparency and information from the administration on what’s happening, what we should expect, the costs,” joining other GOP senators who have expressed similar grievances.
#senate #prices #national
The war continues to be a major drag on GOP candidates as the failure to reopen the Strait of Hormuz and new threats facing oil exports from Iranian-backed Houthi militias have sent the prices to nearly $106 a barrel, while raising the national gas price average to $4.37 a gallon.
But Republicans are particularly concerned about the war’s impact on the price of diesel, which has soared to a national average of $6.31 and hit several Senate battleground states — including Alaska, Nebraska, Iowa and Maine — especially hard.
Some Republicans are now floating the idea of embargoing diesel exports produced in the United States to lower prices.
Republican Sen. Lisa Murkowski (Alaska) expressed frustration over “the lack of just transparency and information from the administration on what’s happening, what we should expect, the costs,” joining other GOP senators who have expressed similar grievances.
#senate #prices #national
1 month ago
Comedian and podcast host Bill Maher called out deep-blue California on Monday and said the state's voters would always support a Democrat, even if their policies were failing, as long as President Donald Trump was ******* ociated with the Republican Party.
During an interview on "Club Random" with David Foster, Maher argued that California would never vote for a Republican as long as Trump was involved in the party.
Maher noted Spencer Pratt, a Republican who finished third in Los Angeles' mayoral race and therefore did not advance to the general election, had the instinct that California had a "failed system," and Maher agreed.
"It just shows that, in this state, I guess everywhere, we're so bipartisan now, that we will accept failure, which we plainly have here in California, over voting for the party of Trump," Maher said. "Which, I understand, because he does a lot of things that are I mean, plus, Jesus, I mean, I get a lot of s--- from him for the things I criticize just off the top of my head, vulgar, corrupt, doesn't concede elections, you know, inept at things that sometimes were a good idea to begin with. Close the border, you know, get rid of nuclear weapons in Iran, but f---ed up the execution."
Bill Maher argued California will never vote for a Republican as long as President Donald Trump is involved in the party, even as failures mount.
#maher #republican #president
During an interview on "Club Random" with David Foster, Maher argued that California would never vote for a Republican as long as Trump was involved in the party.
Maher noted Spencer Pratt, a Republican who finished third in Los Angeles' mayoral race and therefore did not advance to the general election, had the instinct that California had a "failed system," and Maher agreed.
"It just shows that, in this state, I guess everywhere, we're so bipartisan now, that we will accept failure, which we plainly have here in California, over voting for the party of Trump," Maher said. "Which, I understand, because he does a lot of things that are I mean, plus, Jesus, I mean, I get a lot of s--- from him for the things I criticize just off the top of my head, vulgar, corrupt, doesn't concede elections, you know, inept at things that sometimes were a good idea to begin with. Close the border, you know, get rid of nuclear weapons in Iran, but f---ed up the execution."
Bill Maher argued California will never vote for a Republican as long as President Donald Trump is involved in the party, even as failures mount.
#maher #republican #president
1 month ago
XRP dropped 9% on the CLARITY Act's Senate failure, but Coinbase fell 9%, more exposed to the rulebook the bill would have set.
XRP retains its SEC-CFTC commodity classification and 5 live spot ETFs with $1.7 billion in net inflows, keeping its legal floor intact.
XRP has underperformed Bitcoin on every rate release this month, with $1.25 as the critical support heading into the Fed's afternoon decision.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
On Monday, XRP (CRYPTO:XRP) surged 9.8% to $1.49, while Ripple CEO Brad Garlinghouse told the Senate that "the world was watching." However, two days later, the Senate failed to open debate on the CLARITY Act, and XRP fell to $1.28.
#senate #fell #learn #Monday
XRP retains its SEC-CFTC commodity classification and 5 live spot ETFs with $1.7 billion in net inflows, keeping its legal floor intact.
XRP has underperformed Bitcoin on every rate release this month, with $1.25 as the critical support heading into the Fed's afternoon decision.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
On Monday, XRP (CRYPTO:XRP) surged 9.8% to $1.49, while Ripple CEO Brad Garlinghouse told the Senate that "the world was watching." However, two days later, the Senate failed to open debate on the CLARITY Act, and XRP fell to $1.28.
#senate #fell #learn #Monday
1 month ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
Bitcoin (BTC-USD) opened at $75,586.51 on Wednesday, September 16, 2026, 3.3% lower than Tuesday's opening price. As of 7:12 a.m. ET this morning, the price of bitcoin moved higher to $75,885.53.
Ethereum (ETH-USD) opened at $2,397.64 on Wednesday, September 16, 2026, down 4.6% from Tuesday's opening price. The price of ethereum moved up this morning to $2,404.43 as of 7:12 a.m. ET.
Both bitcoin and ethereum prices are down significantly this morning compared to the same time yesterday, following the failure of the CLARITY Act in the U.S. Senate and ahead of the expectation that the Federal Reserve will raise interest rates later today.
If the Fed does raise rates, it will be the first time in three years.
#Bitcoin #opened #down
Bitcoin (BTC-USD) opened at $75,586.51 on Wednesday, September 16, 2026, 3.3% lower than Tuesday's opening price. As of 7:12 a.m. ET this morning, the price of bitcoin moved higher to $75,885.53.
Ethereum (ETH-USD) opened at $2,397.64 on Wednesday, September 16, 2026, down 4.6% from Tuesday's opening price. The price of ethereum moved up this morning to $2,404.43 as of 7:12 a.m. ET.
Both bitcoin and ethereum prices are down significantly this morning compared to the same time yesterday, following the failure of the CLARITY Act in the U.S. Senate and ahead of the expectation that the Federal Reserve will raise interest rates later today.
If the Fed does raise rates, it will be the first time in three years.
#Bitcoin #opened #down
1 month ago
Zane Smith escaped with no serious injuries following a violent crash in Sunday's Enjoy Illinois 300 at World Wide Technology Raceway. The driver of the No. 38 suffered a brake failure in the closing laps of Stage 2, causing him to spin out and slam driver's side first into the outside retaining wall in turn 1.
As Smith climbed from his car, it was evident he was in pain. The 27-year-old was slow to get out of his battered Front Row Motorsports Ford and was leaning on two NASCAR safety workers as they helped him into the ambulance to take him to the infield care center.
Thankfully, Smith took to social media on Monday with a positive update on his condition.
Immediately after Smith careened with the outside wall following the brake failure, his spotter, Ryan Blanchard, tried to summon his driver over the radio to check on his condition.
"We lost brakes here. Let me know if you're OK. Really big hit. Talk to me when you can, please. Let me know if you're OK," he said.
#brake #failure #wall
As Smith climbed from his car, it was evident he was in pain. The 27-year-old was slow to get out of his battered Front Row Motorsports Ford and was leaning on two NASCAR safety workers as they helped him into the ambulance to take him to the infield care center.
Thankfully, Smith took to social media on Monday with a positive update on his condition.
Immediately after Smith careened with the outside wall following the brake failure, his spotter, Ryan Blanchard, tried to summon his driver over the radio to check on his condition.
"We lost brakes here. Let me know if you're OK. Really big hit. Talk to me when you can, please. Let me know if you're OK," he said.
#brake #failure #wall
1 month ago
Two races into NASCAR's new Chase, the championship standings are already showing how quickly things can change.
Kyle Larson left Darlington 49 points behind Denny Hamlin. One win at Gateway later, he sits second, just nine points back.
Ryan Blaney experienced the opposite. He entered Gateway 16 points behind Hamlin before a brake failure ended his race in 35th. Now he trails by 33.
Next comes Bristol Motor Speedway, and there is no reset waiting on the other side.
Under NASCAR's previous playoff format, drivers raced through elimination rounds with points resets along the way. The 2026 Chase is different. After the initial reseeding, all 10 races count toward the same championship total.
#points #championship
Kyle Larson left Darlington 49 points behind Denny Hamlin. One win at Gateway later, he sits second, just nine points back.
Ryan Blaney experienced the opposite. He entered Gateway 16 points behind Hamlin before a brake failure ended his race in 35th. Now he trails by 33.
Next comes Bristol Motor Speedway, and there is no reset waiting on the other side.
Under NASCAR's previous playoff format, drivers raced through elimination rounds with points resets along the way. The 2026 Chase is different. After the initial reseeding, all 10 races count toward the same championship total.
#points #championship
1 month ago
Jose Delgado will be back.
The rising Ultimate Fighting Championship (UFC) Featherweight prospect suffered a third-round submission loss to top Brazilian contender Jean Silva in the main event of Noche UFC 4 this past weekend (Sat., Sept. 12, 2026) inside Desert Diamond Arena in Glendale, Arizona (watch highlights).
Delgado accepted the biggest opportunity of his career on approximately three weeks' notice, replacing former interim Featherweight champion Yair Rodriguez and headlining a UFC event in front of his hometown crowd.
After taking a day to gather his thoughts, Delgado released a statement addressing the first main event loss of his UFC career.
"Well, ***** , so it goes," Delgado wrote on Instagram. "Dared to be great yesterday and came up short. But man, I loved every second of being on that stage with high-level opposition; that includes the heartbreaking pain of failure. Pure freedom. Insert something cliche about bouncing back here. Thank you to God for His guidance and my village for backing me. Also, thanks to everyone in that arena for making that walk what it was. Love y'all."
#main
The rising Ultimate Fighting Championship (UFC) Featherweight prospect suffered a third-round submission loss to top Brazilian contender Jean Silva in the main event of Noche UFC 4 this past weekend (Sat., Sept. 12, 2026) inside Desert Diamond Arena in Glendale, Arizona (watch highlights).
Delgado accepted the biggest opportunity of his career on approximately three weeks' notice, replacing former interim Featherweight champion Yair Rodriguez and headlining a UFC event in front of his hometown crowd.
After taking a day to gather his thoughts, Delgado released a statement addressing the first main event loss of his UFC career.
"Well, ***** , so it goes," Delgado wrote on Instagram. "Dared to be great yesterday and came up short. But man, I loved every second of being on that stage with high-level opposition; that includes the heartbreaking pain of failure. Pure freedom. Insert something cliche about bouncing back here. Thank you to God for His guidance and my village for backing me. Also, thanks to everyone in that arena for making that walk what it was. Love y'all."
#main
